DocWire News Editors

DocwireNews

A study assessed economic outcomes associated with controlled versus uncontrolled persistent asthma in patients who were receiving treatment and were considered adherent.&nbsp;Lulu K. Lee, PhD,&nbsp;of the Health Outcomes Practice at Kantar Health in San Mateo, California, and colleagues found that uncontrolled asthma is associated with higher work impairment, healthcare resource utilization, and costs. The results were presented at the 2018 AAAAI Annual Meeting.The researchers identified 242 patients with controlled asthma and 564 patients with uncontrolled asthma from the 2015 and 2016 U.S. National Health and Wellness Survey. Adherence was assessed with the Morisky Medication Adherence Scale, and patients with medium/high adherence were considered &ldquo;adherent.&rdquo; The researchers also used the Asthma Control Test, with scores of &le;19 signifying uncontrolled disease and scores ranging from 20 to 25 signifying controlled disease. They assessed the following economic outcomes:<ul>
<li>Work Productivity and Activity Impairment-General Health Scale</li>
<li>Health resource utilization</li>
<li>Annual indirect and direct costs</li>
</ul>The mean patient age was 49 years, and more than half (66.7%) were female.Patients with uncontrolled disease experienced 1.4 times greater work productivity loss compared with those with controlled disease (adjusted mean=34.96% vs 25.21%;&nbsp;P=.036). The loss in productivity led to those with uncontrolled disease to experience 1.5 times higher annual indirect costs compared with those with controlled disease (adjusted mean=$11,537 vs $7,630;&nbsp;P=.016).Uncontrolled disease was also associated with twice as many annual hospitalizations (adjusted mean = 0.26 vs 0.12;&nbsp;P&lt;.036) and significantly more medical visits, including:<ul>
<li>Emergency department: adjusted mean=0.53 vs 0.31 (P=.003)</li>
<li>Healthcare provider: adjusted mean=7.83 vs 6.14 (P=.011)</li>
</ul>This led to 1.5 times higher annual direct costs for those with uncontrolled disease (adjusted mean=$31,793 vs $21,240;&nbsp;P&lt;.001).&ldquo;Significant unmet need in asthma management, independent of adherence or asthma severity, was demonstrated [in the study],&rdquo; the authors concluded, noting that a better understanding of treatment needs could improve control and reduce the economic burden.Source: Lee LK, Lugogo NL, Carpinella C, et al. The economic impact of uncontrolled asthma among treated, adherent patients with persistent asthma. Abstract #700. Presented at the 2018 AAAAI Annual Meeting, March 2-5, 2018, Orlando, FL.

Eric Bergson, MD

Rob Dillard

The Role of Multidisciplinary Care in Head and Neck Cancer

Head and Neck Cancer

Sara Nunnery, MD, MSCI

Trastuzumab Deruxtecan in HER2-Low Breast Cancer: Who’s the Right Patient?

HER2 Breast Cancer

Meghan Sise, MD

Joel M. Topf, MD, FACP

Redefining Carboplatin Dosing

NKF Spring Clinical Meetings 2025

Latest News

Uncontrolled Asthma Is an Economic Burden

AAAAI 2018

A study assessed economic outcomes associated with controlled versus uncontrolled persistent asthma in patients who were receiving treatment and were considered ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe